Clinical Trial Update: Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect [Phase 1]

View source ↗

Summary

Phase 1 trial using collagen-targeted PET imaging to assess the effect of epigallocatechin gallate (EGCG) in idiopathic pulmonary fibrosis; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• EGCG (epigallocatechin gallate)

Snippet

Sponsor: Hal Chapman | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED